Autolus Therapeutics Ratios (2017-2025) | AUTL

Ratios Sep2017 Dec2017 Sep2018 Dec2018 Dec2019 Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
100.00%-39,165.52%-99.86%-16.83%-35.15%-4.29%
EBT Margin (Quarter)
-7,855.74%-22,342.17%-3,082.43%-11,298.03%-521.76%-90,151.72%-756.36%-227.12%-370.79%-376.78%
EBIT Margin (Quarter)
-8,449.32%-21,798.80%-3,030.03%-10,567.73%-383.73%-261,600.00%-726.34%-292.58%-337.93%-298.35%
EBITDA Margin (Quarter)
-8,856.76%-26,817.47%-2,644.74%-12,730.54%-521.11%-192,696.55%-657.90%-138.36%-400.59%-373.70%
Operating Margin (Quarter)
-8,449.32%-21,798.80%-3,030.03%-10,567.73%-383.73%-261,600.00%-726.34%-292.58%-337.93%-298.35%
Net Margin (Quarter)
-6,975.68%-22,326.51%-3,081.35%-11,292.86%-521.68%-95,193.10%-781.13%-229.02%-373.30%-371.90%
FCF Margin (Quarter)
-8,178.04%-3,568.96%-11,683.50%-406.62%-99,186.21%-933.07%-382.63%-341.17%-199.91%
Efficiency
Inventory Average (Quarter)
9.39M19.30M25.83M30.47M
Assets Average (Quarter)
263.71M278.87M298.88M349.90M384.78M338.99M288.90M377.05M475.12M455.48M428.55M390.74M638.41M877.53M840.55M805.11M764.53M733.66M691.46M625.51M
Equity Average (Quarter)
244.05M243.74M232.44M261.68M292.23M242.83M187.84M229.91M282.80M248.13M204.93M146.00M346.75M554.94M502.40M452.14M399.22M358.79M305.96M221.79M
Invested Capital (Quarter)
232.64M254.84M210.03M313.32M271.14M214.52M161.15M298.67M266.92M229.34M180.52M111.47M582.03M527.84M476.96M427.32M371.11M346.46M265.45M178.13M
Asset Utilization Ratio (Quarter)
0.000.000.000.000.000.000.000.000.000.000.000.000.020.010.010.010.010.040.070.12
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-20.22-21.58-20.19-3.37-7.98-8.84-8.56-1.77-2.01-5.79-6.352.46-6.438.96-6.81-3.17
Debt to Equity (Quarter)
0.00
Debt Ratio (Quarter)
0.00
Equity Ratio (Quarter)
0.920.840.710.770.740.680.610.610.580.510.440.300.650.620.580.550.500.480.400.30
Times Interest Earned (Quarter)
-20.22-21.58-20.19-3.37-7.98-8.84-8.56-1.77-2.01-5.79-6.352.46-6.438.96-6.81-3.17
Valuation
Enterprise Value (Quarter)
-217.66M-212.22M-0.79M-310.68M-268.89M-216.76M-163.37M-382.76M-343.36M-307.83M-256.85M-240.34M-759.54M-706.96M-658.54M-228.81M-97.25M-125.33M-367.42M-105.64M
Return Ratios
Return on Sales (Quarter)
-69.76%-138.34%-220.88%-69.76%-223.27%-476.63%-734.27%-896.79%-30.81%-120.05%-112.93%-122.72%-5.22%-22.27%-26.76%-951.93%-7.81%-2.29%-3.73%-3.72%
Return on Capital Employed (Quarter)
-0.36%-0.52%-0.55%-0.38%-0.29%-0.32%-0.35%-0.52%-0.30%-0.23%-0.28%-0.32%-0.38%-0.41%-0.45%-0.49%
Return on Invested Capital (Quarter)
-0.40%-0.61%-0.72%-0.62%-0.52%-0.61%-0.77%-1.23%-0.52%-0.35%-0.44%-0.54%-0.68%-0.77%-0.91%-1.23%
Return on Assets (Quarter)
-0.28%-0.26%-0.22%-0.06%-0.10%-0.23%-0.42%-0.39%-0.32%-0.34%-0.37%-0.53%-0.35%-0.27%-0.32%-0.27%-0.31%-0.31%-0.33%-0.46%
Return on Equity (Quarter)
-0.30%-0.30%-0.28%-0.08%-0.13%-0.33%-0.65%-0.65%-0.54%-0.63%-0.77%-1.43%-0.64%-0.42%-0.54%-0.49%-0.60%-0.63%-0.73%-1.30%